MGL is critically important for efficient degradation of MG since it has been shown in mouse models that lack of MGL impairs lipolysis and is associated with increased MG levels in adipose and nonadipose tissues alike
However, this digestive slowing can also lead to side effects such as nausea, bloating, and altered bowel habits
In ACHIEVE-3, orforglipron outperformed oral semaglutide across the primary and all key secondary endpoints, delivering significantly greater improvements in A1C and weight.1,2 The results were published today in The Lancet
For instance, significant gastrointestinal side effects leading to dehydration, or episodes of hypoglycaemia in susceptible individuals, might produce dizziness or light-headedness that patients interpret as vertigo
Frequently Asked Questions Q: What solvent should I use to reconstitute retatrutide